ValiRx - Half-year Report 2017
VAL
Tue, 26 Sep 2017, 03:45pm BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Oliver de Giorgio-Miller speaks about the encouraging pre-clinical and clinical portfolio and the significant progress across the therapeutical portfolio.